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Ail	 	 	 	 Attachment	and	invasion	locus	protein	
BamA	 	 	 	 Outer	membrane	protein	assembly	factor	BamA	
CDC	 	 	 	 Centers	of	Disease	Control	and	Prevention	of	the	United	States	
CFU	 	 	 	 Colony	Forming	Unit	
CIN-Agar	 	 	 Cefsulodin-Irgasan-Novobiocin-Agar	
ClpP	 	 	 	 Caseinolytic	protease	P	
CS3	 	 	 	 Coli	Surface	antigen	3	
d	 	 	 	 day	
DD	 	 	 	 Differential	Diagnosis	
DGVS	 	 	 	 Deutsche	Gesellschaft	für	Verdauungs-	und	
Stoffwechselerkrankungen	
DNA	 	 	 	 Deoxyribonucleic	Acid	
E.	coli	 	 	 	 Escherichia	coli	
ECM	 	 	 	 Extracellular	Matrix	
e.	g.		 	 	 	 example	gratia	=	for	example	
et	al.	 	 	 	 et	alii	/	aliae	
ETEC	 	 	 	 Enterotoxic	Escherichia	coli	
Fe	2+	 	 	 	 Ferrous	iron	(iron	with	oxidation	number	of	+2)	
Fe	3+	 	 	 	 Ferric	iron	(iron	with	oxidation	number	of	+3)	
Fur	 	 	 	 Fe-uptake	regulation	
FyuA	 	 	 	 Ferric-yersiniabactin	uptake	
g	 	 	 	 gram	
GALT	 	 	 	 Gut	Associated	Lymphoid	Tissue	
Hfq	 	 	 	 Host	factor	of	bacteriophage	Q	beta	
HPI	 	 	 	 High	Pathogenicity	Island	
IfSG	 	 	 	 Infektionsschutzgesetz	
IM	 	 	 	 Inner	Membrane	
InvA	 	 	 	 Invasin	A	
IS	 	 	 	 Insertion	Sequence	
i.	v.		 	 	 	 intravenous	
kb	 	 	 	 kilobase	
kDa	 	 	 	 kilo	Dalton	
KDO	 	 	 	 Keto-deoxyoctulosonate	
lac	 	 	 	 lactose	
LB	 	 	 	 Luria-Bertani	medium	
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lcr	 	 	 	 low	calcium	response	
LBP	 	 	 	 LPS	binding	protein		
LPS	 	 	 	 Lipopolysaccharide	
LpxR	 	 	 	 Lipid	A	3ʹ-O-deacylase,	produces	tetra-acylated	LPS	
MAPK	 	 	 	 Mitogen-Activated	Protein	Kinase		
MarR	 	 	 	 Multiple	antibiotic	resistance	Regulator	
M	cells	 	 	 	 Microfold	cells	
mg	 	 	 	 milligram	
mRNA	 	 	 	 messenger	Ribonucleic	Acid	
Myf	 	 	 	 Mucoid	yersinia	factor	 	 	
nm	 	 	 	 nanometer	
nt	 	 	 	 nucleotide	
O-Ag	 “Hitzestabiles	 Oberflächenantigen”	 of	 Gram-negative	 bacteria,	
exposed	repetitive	oligosaccharide	units	
OD600	 	 	 	 Optical	Density	(600nm)	
OM	 	 	 	 Outer	Membrane	
OmpX	 	 	 	 Outer	membrane	protein	X	
OmpR	 	 	 	 Outer	membrane	protein	Regulator	
PBS	 	 	 	 Phosphate	Buffered	Saline	
PhoP	 	 	 	 Transcriptional	regulatory	protein	of	the	phosphate	regulon	
PmrA	 	 	 	 Polymyxin-resistance-associated	response	regulator	A	
p.	o.		 	 	 	 per	os	
pYV	 	 	 	 Plasmid	of	Yersinia	Virulence	
RBS	 	 	 	 Ribosome	Binding	Site	
RNA	 	 	 	 Ribonucleic	Acid	
RovA	 	 	 	 Regulator	of	virulence	
SDS-PAGE		 	 	 Sodium	Dodecyl	Sulfate	Polyacrylamide	Gel	Electrophoresis	
Sec	 	 	 	 general	Secretion	System		
spp.		 	 	 	 species	pluralis	
sRNA	 	 	 	 small	Ribonucleic	Acid	
T3SS	 	 	 	 Type	Three	Secretion	System/	Type	III	Secretion	System	
T5SS/TVSS	 	 	 Type	Five	Secretion	System	(comprising	5	subtypes:	TVaSS	–	TVeSS)	
TLR4	 	 	 	 Toll-like	Receptor	4	
VirF	 	 	 	 Virulence	regulon	transcriptional	activator	
VYE-Agar	 	 	 Virulent	Yersinia	enterocolitica	Agar	
wt	 	 	 	 wildtype	
8	
Ybt	 	 	 	 Yersiniabactin	
YadA	 	 	 	 Yersinia	adhesin	A	
Yop	 	 	 	 Yersinia	outer	protein	
Ysc	 	 	 	 Yersinia	secretion	system	
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In	 June	 1894	 in	 Hong	 Kong	 bacteriologist	 Alexandre	 Émile	 Jean	 Yersin	 (*1863	 in	 Aubonne,	
Switzerland;	†	1943	in	Nha	Trang,	Vietnam)	discovered,	Yersinia	pestis,	the	agent	of	the	plague	(Bibel	
and	Chen,	1976),	 later	named	 in	his	honour.	He	 isolated	 the	pathogen	 from	pestilential	buboes	of	






species	are	pathogenic	 to	mammals	 (Y.	pestis,	Y.	enterocolitica,	Y.	pseudotuberculosis)	and	one	 for	





Besides	 Yersinia	 pestis,	 which	 causes	 bubonic	 and	 pneumonic	 plague,	 Yersinia	 pseudotuberculosis	
and	 Yersinia	 enterocolitica	 (Koornhof	 et	 al.,	 1999,	 Smego	 et	 al.,	 1999)	 both	 cause	 gastrointestinal	
infections	known	as	yersiniosis.	The	evolutionary	path	of	Y.	pseudotuberculosis	and	Y.	enterocolitica	
is	believed	to	have	diverged	in	the	last	200	million	years	(Heroven	and	Dersch,	2014).	Strikingly,	by	
gene	 loss	and	gene	gain	Y.	pestis	 evolved	 from	Y.	pseudotuberculosis	as	 recently	as	4,000	 -	20,000	
years	ago.	(Achtman	et	al.,	1999,	Bos	et	al.,	2016,	Andrades	Valtuena	et	al.,	2017,	Spyrou	et	al.,	2018).	
Despite	 this	 recent	evolution	of	 this	pathogen	 the	 clinical	 pictures	 and	disease	patterns	 caused	by					
Y.	 pestis	 differ	 significantly	 from	 those	 associated	 with	 infections	 by	 enteropathogenic																										
Y.	pseudotuberculosis	or	Y.	enterocolitica	(Chain	et	al.,	2004,	Derbise	et	al.,	2010).		
The	 essential	 requirement	 of	 pathogenicity	 of	 the	 three	 Yersinia	 species	 is	 the	 presence	 of	 a	 70-
kilobase	 virulence	 plasmid,	 called	 pYV	 (plasmid	 of	 Yersinia	 virulence).	 It	 encodes	 a	 sophisticated	
11	
nanomachine,	 the	Type	3	Secretion	System	(T3SS),	 that	 injects	Yersinia	anti-host	proteins	 into	host	
cells	(Biot	and	Cornelis,	1988,	Cornelis	et	al.,	1989,	Hammerl	et	al.,	2012).		




Yersinia	pestis,	 the	causative	agent	of	plague,	 is	 transmitted	by	fleas	 (e.g.	Xenopsylla	cheopis)	 from	
infected	animals,	mostly	 rodents,	 to	other	animals	 and	at	 times	 to	humans	 (Perry	and	Fetherston,	
1997).	By	biting	infected	animals	fleas	incorporate	blood	containing	the	plague	bacilli.	Transmission	
of	 the	 infection	 is	 favoured	 through	 the	 formation	 of	 bacterial	 clumps	 (biofilm)	 that	 obstruct	 the	
flea’s	 foregut	and	prevent	a	proper	 intake	of	 food.	This	mechanism	promotes	hunger	 in	 the	 insect	
and	 leads	to	an	 increased	search	for	blood	meal	 (Bacot	and	Martin,	1914).	By	 its	next	bite	the	flea	
passes	along	 the	pathogen,	by	 regurgitating	 it	with	 the	 infected	blood,	 to	another	host.	Within	 its	
mammalian	 hosts,	 Y.	 pestis	 invades	 the	 adjacent	 lymphatics,	 becomes	 filtered	 in	 regional	 lymph	
nodes	 and	 proliferates	 there	 forming	 the	 typical	 buboes	 (swollen,	 painful,	 haemorrhagic	 lymph	
glands).	 Subsequently	 it	 can	 affect	 the	 bloodstream,	 lead	 to	 bacteraemia	 and	 finally	 sepsis	with	 a	
high	mortality	rate	in	humans	and	black	rats	(Wren,	2003).	Apart	from	the	bubonic	and	septicaemic	
plague	 the	 third	 form	of	Y.	pestis	 infection	 is	 the	pneumonic	plague	 (Figure	 1).	 Following	 systemic	
spread,	the	bacilli	colonize	the	lungs.	In	addition	the	disease	can	also	be	communicated	directly	from	
person	 to	 person	 by	 droplet	 infection	 (Perry	 and	 Fetherston,	 1997).	 Pneumonic	 plague	 is	 highly	
contagious	and	without	any	treatment	mostly	fatal	(Apangu	et	al.,	2017).	
Throughout	 history	 three	 pandemics	 have	 been	described	 (Spyrou	 et	 al.,	 2016).	 First	 the	 Justinian	
plague,	which	spread	from	541	AD	onwards	around	the	late	antique	Mediterranean	world	and	took	
millions	 of	 lives	 in	 nearly	 two	 centuries	 (Wagner	 et	 al.,	 2014).	 In	 the	 High	Middle	 Ages	 the	 Black	
Death	swept	over	Europe	from	1347-1353	with	outbreaks	 into	the	18th	century.	The	Black	Death	 is	
said	 to	have	 killed	nearly	 one-third	of	 the	population	 in	 Europe	 (Zietz	 and	Dunkelberg,	 2004).	 The	
third	wave	started	in	China	in	the	second	half	of	the	19th	century	and	disseminated	from	Hong	Kong	





2003,	 Carniel,	 2008,	 Butler,	 2013,	 Kugeler	 et	 al.,	 2015,	 Li	 et	 al.,	 2016,	 Gracio	 and	 Gracio,	 2017,	
Kmietowicz,	2017,	Tsuzuki	et	al.,	2017,	Spyrou	et	al.,	2018).		
The	three	historical	pandemics	are	associated	with	three	biovars,	which	can	be	differentiated	based	




Today	 the	 treatment	 of	 choice	 is	 streptomycin,	 gentamicin,	 tetracycline/doxycycline,	














into	 21	 serotypes	 (Wren,	 2003,	 De	 Castro	 et	 al.,	 2009).	 The	most	 commonly	 isolated	 serotypes	 in	




al.,	 2009,	 Heroven	 and	 Dersch,	 2014,	 Jaakkola	 et	 al.,	 2015).	 Despite	 the	 fact	 that																																					
Y.	pseudotuberculosis	is	genetically	closer	to	Y.	pestis	(>	97%	nucleotide	identity)	it	shows	similarity	in	





In	 contrast	 to	 the	very	homogeneous	group	of	Y.	pseudotuberculosis,	Y.	enterocolitica	 comprises	6	
biotypes	 and	 about	 60	 serotypes,	 that	 differ	 from	 each	 other	 not	 only	 biochemically,	 but	 also	
genetically	 and	 in	 terms	 of	 pathogenicity	 (Wauters	 et	 al.,	 1987,	 Garzetti	 et	 al.,	 2012).	 Table	 1	












		 		 		 		
6	biovars	 1A	 1B	 2-5	
		 		 		 		












		 		 		 		
		 		 		 		
Mouse	infection	model	 non-virulent	 highly	virulent	 moderate	virulent	
		 		 (mouse-lethal)	 (non-mouse-lethal)	
		 		 		 		
		 		 		 		
60	serovars	(H-	and	O-antigens)	 O:5,	O:6,30,	O:6,31,	 O:4,	O:8,	O:13,		 O:3,	O:9,	O:5,27	
most	frequently	serovars		 	O:7,8,	O:10	 O:18,	O:20,	O:21	 		
are	listed	here	 	 	 	
		 		 		 		
		 		 		 		
Regional	prevalence	 environmental		 North	America		 Europe	and	Japan	
		 		 =	"new-world	strains"	 =	"old-world	strains"	
		 		 		 		
		 		 		 		
Subspecies	differentiation	
based	on		 Y.	enterocolitica	 Y.	enterocolitica	 Y.	enterocolitica	
16S	rRNA	sequence	 subsp.	parlearctica	 subsp.	enterocolitica	 subsp.	parlearctica	











Weigand	et	al.,	 2014).	Pigs	are	 considered	 to	be	a	main	 reservoir	 (infected	pharyngeal	 tonsils)	but	
also	other	domestic	and	wild	animals	such	as	wild	boars	(>	90%	colonized),	sheep	and	goats	can	be	
colonized	or	 infected	 (Fredriksson-Ahomaa	et	al.,	2009,	 Joutsen	et	al.,	2016,	European	Food	Safety	
Authority	 and	 European	 Centre	 for	 Disease	 Prevention	 and	 Control	 (EFSA	 and	 ECDC),	 2018).																
Y.	pseudotuberculosis	is	more	often	isolated	in	Eastern	Europe	and	Russia,	but	Y.	pseudotuberculosis	
infections	are	generally	less	frequent	(Galindo	et	al.,	2011,	Herold,	2014).	Enteropathogenic	yersiniae	
can	 still	multiply	 at	 temperatures	 of	 4°C,	which	means	 the	 pathogen	 can	 grow	on	 foods	 stored	 in	
refrigerators	for	example.	The	main	source	of	infection	in	humans	is	contact	with	animals	bearing	the	
pathogen	 or	 by	 consuming	 contaminated	 food,	 especially	 milk	 products	 and	 raw	 or	 undercooked	
pork	for	Y.	enterocolitica	(Bottone,	1999)	and	contaminated	vegetables	and	lettuce	(e.g.	by	rats)	for		
Y.	 pseudotuberculosis	 (Heroven	 and	 Dersch,	 2014).	 The	 typical	 route	 of	 infection	 is	 the	 fecal-oral	
route,	 but	 also	 severe	Y.	 enterocolitica	 infections	 have	 been	 reported	 through	 blood	 transfusions,	







other	 enteropathogenic	 bacteria	 such	 as	 salmonellae	 (Leung	 and	 Finlay,	 1991)	 or	 shigellae	
(Sansonetti,	 1993,	 Parsot	 and	 Sansonetti,	 1996),	 Y.	 enterocolitica	 multiplies	 extracellularly	 and	 by	
using	predominantly	 the	 lymphatic	and	occasionally	 the	vascular	 system	 (Autenrieth	and	Firsching,	
1996)	 it	 not	 only	 leads	 to	micro-abscesses	 in	 the	 regional	 lymph	 nodes,	 but	 also	 in	 other	 organs,	
mainly	the	 liver	and	spleen	(Autenrieth	and	Firsching,	1996,	Autenrieth	et	al.,	1996,	Hopfner	et	al.,	















































































Irgasan-Novobiocin-Agar	 (Schiemann,	 1979))	 or	 VYE-Agar	 (=	 virulent	 Yersinia	 enterocolitica	 agar,	
(Fukushima,	1987))	or	enriched	by	incubation	of	stool	sample	in	PBS	at	4°C	for	three	weeks,	because	
of	their	growth	advantage	at	4°C	compared	to	other	bacteria	(Eiss,	1975,	Greenwood	et	al.,	1975).		








In	 these	 cases	 the	 S2k-guidelines	 from	 the	 DGVS	 (Deutsche	 Gesellschaft	 für	 Verdauungs-	 und	











According	 to	 the	 German	 Infection	 Protection	 Law	 the	 laboratory	 detection	 of	 enteropathogenic	
Yersiniae	spp.	have	to	be	reported	to	the	responsible	public	health	department	(IfSG,	2000).		
	





“The	 varied	 ecology,	 pathogenicity	 and	 host	 range	 of	 these	 related	 species,	 together	 with	 the	
availability	of	mouse	models	for	both	gastroenteritis	and	plague	that	mimic	human	disease,	and	the	
relative	ease	of	constructing	defined	mutants,	make	the	yersiniae	a	model	genus	in	which	to	study	the	
genetics	 and	 evolution	 of	 bacterial	 pathogens.”	 This	 is	 how	Wren	 describes	 yersiniae	 in	 his	 2003	
review	(Wren,	2003).		
	
As	enteropathogenic	yersiniae	are	also	pathogenic	 to	rodents	 (e.g.	mice,	 rats	and	rabbits)	 they	are	
used	as	model	organisms	to	unravel	the	pathomechanisms	on	a	cellular	and	molecular	level.			






invasion	 and	 infection	 take	 place,	 the	 human	 small	 intestine,	 they	undergo	 different	 temperature	









et	 al.,	 1994,	 Iriarte	 and	 Cornelis,	 1995,	 de	 Koning-Ward	 and	Robins-Browne,	 1997,	 Bottone,	 1999,	












































the	 bacteria	 lose	motility	 (no	 flagella	 production	 at	 37°C)	 and	 tend	 to	 autoaggregate	 through	 the	






Figure	 2:	 Summary	 of	 important	 virulence	 factors	 of	 Yersinia	 enterocolitica	 serotype	 O:8.	 T3SS	














this	 injectisome,	 including	 a	 basal	 part,	 that	 spans	 the	 bacterial	 membrane	 and	 a	 distal	 needle	





2012).	 Once	 in	 the	 cytosol	 of	macrophages	 or	 neutrophils	 Yops	 reveal	 their	 biochemical	 activities	
resulting	 in	 the	 inhibition	 of	 phagocytosis	 and	 downregulation	 of	 the	 inflammatory	 response	
(Cornelis,	 2002a,	 Heesemann	 et	 al.,	 2006).	 The	 molecular	 function	 of	 the	 six	 effector	 Yops	 of															
Y.	enterocolitica	have	been	intensively	studied	(Young,	2007,	Zhao	and	Shao,	2015):		













that	 is	 also	 encoded	 on	 the	 pYV-plasmid	 (Cornelis	 et	 al.,	 1989).	 The	 translation	 of	 lcrF	 m-RNA	 is	
temperature-dependent	 regulated	 (see	 1.6.)	 (Schwiesow	 et	 al.,	 2015,	 Nuss	 et	 al.,	 2017).	 The	
physiological	 role	 of	 T3SS	 is	 believed	 to	 act	 mainly	 as	 a	 needle	 for	 Yop	 injection	 into	 host	 cells	
without	the	release	of	Yop	effectors	into	the	extracellular	milieu	(Rosqvist	et	al.,	1994,	Cornelis	and	








Another	 crucial	 protein	 encoded	 by	 the	 pYV-plasmid	 is	 the	 Yersinia	 adhesin	 A	 (YadA),	 a	 trimeric	
autotransporter	protein	(monomer	=	41-44	kDa)	belonging	to	the	Type	Vc	Secretion	System.	Type	V	
secretion	systems	(TVSS)	comprise	five	subtypes:	TVaSS,	TVbSS,	TVcSS,	TVdSS	and	TVeSS	(Meuskens	
et	 al.,	 2019).	 The	 C-terminal	 domains	 form	 a	 12-stranded	 β-barrel	 in	 the	 outer	 membrane	
(translocator).	The	 three	surface-exposed	N-terminal	domains	 form	a	homo-trimeric	coiled-coil	 rod	
with	an	oval	head	domain	(lollipop-like	structure)	that	can	be	detected	as	a	heat-stable	protein	band	
of	about	160-250	kDa	in	SDS-PAGE	(see	Figure	2)	(Skurnik	and	Wolf-Watz,	1989,	Tamm	et	al.,	1993,	
Gripenberg-Lerche	 et	 al.,	 1995,	 Hoiczyk	 et	 al.,	 2000,	 El	 Tahir	 and	 Skurnik,	 2001,	 Leo	 et	 al.,	 2012,	
Meuskens	et	al.,	2019).		
	YadA	 is	 produced	mainly	 at	 37°C	 but	 can	 be	 detected	 in	 lesser	 amounts	 at	 25°C	 (Bottone,	 1999).	
Electronic	 microscopy	 has	 revealed	 that	 this	 abundant	 protein	 covers	 nearly	 the	 entire	 bacterial	
surface	explaining	the	increased	hydrophobic	property	of	enteropathogenic	yersiniae	cells	grown	at	
37°C	(Bolin	et	al.,	1982,	Hoiczyk	et	al.,	2000,	El	Tahir	and	Skurnik,	2001).	YadA	binds	to	extracellular	
matrix	 (ECM)	proteins	 (collagen,	 laminin,	 fibronectin),	 the	 intestinal	submucosa,	mucus	and	also	 to	
hydrophobic	 surfaces,	 for	 example	 polystyrene	 (Lachica	 and	 Zink,	 1984a,	 Lachica	 and	 Zink,	 1984b,	




YadA	 also	 plays	 a	 crucial	 role	 in	 serum	 resistance	 of	 Y.	 enterocolitica	 through	 prevention	 of	 the	
activation	 of	 the	 classical	 complement	 pathway	 (Heesemann	 and	 Laufs,	 1983,	 Heesemann	 and	
Grüter,	1987,	Roggenkamp	et	al.,	1996,	Biedzka-Sarek	et	al.,	2008).		
Moreover	YadA	is	made	responsible	for	chronification	of	Yersiniosis	and	the	occurrence	of	sequelae	










Another	major	adhesin	 in	enteropathogenic	yersiniae	 is	 invasin	 InvA	(or	 Inv)	 (Isberg	et	al.,	1987),	a	
92kDa	OM	protein	encoded	on	the	Yersinia	chromosome	by	the	inv	locus.	InvA	is	expressed	optimally	
at	 28°C	 but	 can	 also	 be	 detected	 at	 37°C,	 but	 preferentially	 under	 acidic	 pH-conditions	 (Pepe	 and	
Miller,	1993,	Pepe	et	al.,	1994).		
InvA	binds	directly	 to	β1-integrin	and	promotes	M	cell	penetration	and	translocation	 in	early	stage	
disease	 of	 oral	 infection	 (see	 Figure	 2)	 (Isberg	 and	 Leong,	 1990).	 In	 contrast	 to	 YadA,	 InvA	 is	 a	
monomeric	adhesin,	which	forms	an	N-terminal	12-stranded	β-barrel	 in	the	outer	membrane	(OM)	
with	 a	 surface-exposed	 C-terminal	 domain.	 Therefore	 InvA	 is	 assigned	 to	 the	 Type	 Ve	 Secretion	
System	(Leo	et	al.,	2012,	Meuskens	et	al.,	2019).	InvA	expression	is	controlled	by	RovA	(Regulator	of	
virulence),	 a	 MarR-type	 transcriptional	 regulator	 (Multiple	 antibiotic	 resistance	 Regulator),	 that	
autoregulates	 its	own	production	(Revell	and	Miller,	2001).	RovA	binds	to	regulatory	regions	of	the	









and	 infection	 pathway	 (Simonet	 et	 al.,	 1996).	 However	 the	 transcriptional	 activator	 RovA	 is	







adhesins.	 The	 17-kDa	 surface-exposed	 protein	 is	 encoded	 chromosomally	 and	 consists	 of	 eight	β-
sheets	spanning	the	bacterial	membrane	and	exposing	four	loops	to	the	surface	(Miller	et	al.,	1990,	
Beer	 and	Miller,	 1992,	Miller	 et	 al.,	 2001,	Mikula	 et	 al.,	 2012).	 The	 loops	 initiate	 attachment	 and	





production	by	 the	ClpP	protease	 complex	 (Pederson	et	 al.,	 1997).	 Pathogenic	 yersiniae	produce	at	
least	 one	 other	 Ail-like	 protein	 called	 OmpX.	 	 Although	 the	 function	 of	 OmpX	 has	 not	 yet	 been	




The	Myf	 fimbriae	 (Mucoid	 Yersinia	 factor)	 are	 produced	 by	 Y.	 enterocolitica	 at	 37°C	 at	 acidic	 pH	
(Iriarte	and	Cornelis,	1995).	They	are	 fimbriae-like	polymers	of	 the	21-kDa	MyfA	subunits.	The	myf	








MyfB	 and	MyfC	 incorporate	MyfA	 subunits	 to	 the	 growing	 pilus	 that	 protrudes	 through	 the	 outer	
membrane	(Iriarte	et	al.,	1993,	Iriarte	and	Cornelis,	1995).		
MyfA	 is	 only	 found	 in	Y.	 enterocolitica	 strains	 that	 are	 virulent	 (Iriarte	 et	 al.,	 1993).	 The	particular	
functions	of	MyfA	in	the	pathogenicity	of	Y.	enterocolitica	have	not	been	identified	yet.	Nevertheless	
it	 can	 be	 detected	 during	 infection	 and	 can	 be	 taken	 for	 serum	 tests	 to	 diagnose	




Moreover,	 there	 are	 clear	 similarities	 between	 the	optimal	 conditions	 for	 expression	of	 these	 two	
proteins;	 both	 are	 maximally	 produced	 at	 37°C	 under	 acidic	 conditions.	 However	 the	 resulting	














Reines	 et	 al.,	 2012a)	 that	 are	 anchored	 to	
the	 outer	 lipid	 leaflet	 of	 the	 OM.	 When	
released	 during	 destruction	 of	 the	
pathogen	 and	 in	 this	 free	 form	 lipidA	
functions	 as	 an	 endotoxin,	 inter	 alia	
causing	 fever,	 inflammation,	 apoptosis.	 In	
the	 blood	 circulation	 LPS	 binding	 protein	
(LBP)	 and	 CD14	 interact	 with	 LPS.	 These	
complexes	 induce	 an	 inflammatory	
response	of	leukocytes	by	activation	of	the	
TLR4	 complex	 (Park	and	 Lee,	2013).	 LPS	 is	
relatively	 heat-stable	 and	 can	 only	 be	
eliminated	 with	 special	 sterilization	
methods	 such	 as	 dry	 heat	 at	 250°C	 for	 at	
least	30	minutes	(Tsuji	and	Harrison,	1978,	
Miyamoto	et	al.,	2009).		
(2)	 The	 core	 is	 composed	 of	
oligosaccharides	 linked	 to	 the	 lipid	 A	 by	
keto-deoxyoctulosonate	(KDO)	that	can	be	
divided	 into	 inner	 and	outer	 core	 (Skurnik	
and	Toivonen,	2011).		
(3)	 The	 O-antigen	 structure	 is	 a	 variable,	
one	 or	 two-linked,	 polysaccharide	 chain.	
While	lipid	A	and	the	core	oligosaccharides	
are	 relatively	 conserved	 within	 different	
bacteria	genera	and	species,	the	O-antigen	
shows	 many	 structural	 variations	 and	 is	
highly	heterogeneous	even	within	different	
strains	of	the	same	species	(Jansson	et	al.,	
1981,	 Di	 Genaro	 et	 al.,	 2000),	 a	 feature	
used	as	the	basis	of	serological	serotyping.	 	
Figure	 3:	 Schematic	 representation	 of																				







the	 flippase	 Wzx.	 The	 polymerase	 Wzy	 polymerizes	 them	 at	 the	 periplasmic	 side	 of	 the	 inner	
membrane	and	Wzz	controls	the	chain	length	(Bengoechea	et	al.,	2002a).	The	O-Ag	is	then	ligated	to	
the	 lipid	 A	 and	 then	 exported	 to	 the	 bacterial	 surface	 on	 the	 outer	 membrane	 (Skurnik	 and	
Bengoechea,	2003).		 	 	
Importantly,	 the	O-antigen	plays	a	significant	 role	 in	 the	virulence	of	Y.	enterocolitica	 serotype	O:8	
(Zhang	 et	 al.,	 1997,	 Darwin	 and	 Miller,	 1999,	 Bengoechea	 et	 al.,	 2004).	 Accordingly,	 it	 promotes	
resistance	 to	 serum	 and	 to	 antimicrobial	 peptides	 and	 also	 modulates	 the	 function	 and/or	
abundance	of	the	adhesins	YadA,	Ail	and	InvA	(Bengoechea	et	al.,	2004).		
	
In	 addition	 to	 the	 O-antigen,	 other	 LPS	 modifications	 are	 linked	 with	 virulence	 and	 resistance	 to	
antimicrobial	peptides	(Reines	et	al.,	2012a,	Reines	et	al.,	2012b,	Simpson	and	Trent,	2019).	Thus	the	
acylation	 grade	 plays	 an	 important	 role.	 Hexa-acylated	 lipid	 A	 (possibly	 in	 addition	 with	
aminoarabinose	or	palmitate)	 causes	a	 strong	activation	of	 the	TLR4-pathway,	while	 tetra-acylated	










Some	 bacteria	 carry	 so-called	 pathogenicity	 islands,	 genomic	 regions	 acquired	 by	 horizontal	 gene	
transfer	 and	 that	 carry	 genes	 for	 virulence	 factors	 (Hacker	 et	 al.,	 2003).	 The	 Yersinia	 High	
Pathogenicity	 Island	 (HPI)	 is	 a	 chromosomal	 gene	 cluster	 governing	 siderophore	 biosynthesis,	
regulation	 and	 transport.	 As	 the	 name	 implies,	 within	 yersiniae	 it	 is	 only	 found	 in	 the	 highly	
pathogenic	 strains:	 mouse-virulent	 Y.	 enterocolitica	 biotype	 1B,	 Y.	 pseudotuberculosis	 (most	
serotypes)	and	Y.	pestis	(Schubert	et	al.,	1998).	Interestingly	HPI	can	be	also	present	in	other	species	
of	 the	 family	of	Enterobactericeae	 causing	systemic	 infections	 in	humans,	 such	as	E.	 coli,	Klebsiella	
oxytoca,	Citrobacter	koseri	(Schubert	et	al.,	2004).	
Iron	 is	essential	 for	almost	all	 living	organisms	and	for	many	microbes	(inter	alia:	respiratory	chain,	
DNA	synthesis).	Although	 the	element	 iron	 is	abundant	on	our	planet	 it	 is	not	 readily	available	 for	
26	
microorganisms	 as	 it	 is	 usually	 found	 chelated	 to	 specific	 compounds	 or	 in	 poorly	 soluble	 form.		
Moreover,	 in	 the	case	of	pathogens,	 the	host	 restricts	 the	concentration	of	 free	 iron	by	binding	 to	





then	 the	 iron	 can	 be	 freed	 and	 utilized	 e.g.	 by	 reduction	 to	 the	 soluble	 Fe2+	 (ferrous	 iron)																	
(see	Figure	2)	or	stored	intracellularly	by	bacterioferritin	(Neilands,	1995,	Rivera,	2017).		
Yersiniabactin	 (Ybt)	 is	 a	 low	molecular	 weight	 siderophore	 and	 closely	 related	 to	 the	 siderophore	
pyochelin	 of	 Pseudomonas	 aeruginosa.	 Ybt	 is	 responsible	 for	 the	 iron-uptake	 in	 highly	 virulent	




























This	 multisubunit	 metalloenzyme	 (requires	 nickel	 in	 its	 active	 centre)	 is	 highly	 conserved	 among	
many	 bacteria	 species,	 but	 shows	 some	 specific	 characteristics	 for	 Y.	 enterocolitica.	 Within																		
Y.	enterocolitica	urease	reaches	its	top	reaction	rate	at	pH	3,5	–	4,5	and	is	more	active	at	28°C	than	at	
37°C	 (de	 Koning-Ward	 and	Robins-Browne,	 1997).	With	 a	 small	 amount	 of	 substrate	 available	 this	
cytoplasmic	protein	 can	 convert	 at	maximum	rate	of	hydrolysis,	demonstrating	a	 strong	affinity	 to	
environmental	urea.	In	contrast	to	other	ureolytic	bacteria	it	is	not	regulated	by	urea	(as	for	example	
in	 Proteus	 mirabilis	 (Jones	 and	 Mobley,	 1988)	 or	 nitrogen	 availability	 (as	 in	 Klebsiella	 aerogenes	
(Friedrich	 and	 Magasanik,	 1977)),	 or	 acidic	 surrounding	 conditions,	 but	 by	 growth	 phase.	 Urease	
activity	 is	 highest	 in	 stationary	 phase	 (de	 Koning-Ward	 and	Robins-Browne,	 1997).	 Integrating	 this	
knowledge	 into	the	 life	cycle	of	enteropathogenic	yersiniae,	we	speculate	that	 food-borne	bacteria	
are	 likely	to	be	 in	stationary	phase	and	also	at	 low	temperature	and	therefore	are	 likely	to	contain	





strains	 and	 is	 not	 present	 in	 non-pathogenic	 biovars	 (Delor	 et	 al.,	 1990).	 Resembling	 the	 E.	 coli	




growth	 phase	 (Delor	 and	 Cornelis,	 1992,	 Amirmozafari	 and	 Robertson,	 1993).	 In	 standard	 culture	
media	Yst	is	expressed	below	30°C,	but	yst	transcription	can	also	be	detected	at	37°C	upon	growth	in	




During	 its	 life	 cycle,	 Y.	 enterocolitica	 continuously	 adapts	 to	 changes	 in	 its	 environment	 which	
enables	 it	 to	survive	and	multiply,	evade	the	host’s	defence	system	and	cause	disease.	All	of	 these	
processes	require	an	efficient	and	reactive	fine-tuned	regulation	of	gene	expression.	But	how	is	the	
gene	expression	and	protein	synthesis	regulated	and	coordinated	in	a	fine-tuned	fashion?	How	does	
the	 bacterium	produce	 the	 right	 virulence	 factors	 during	 the	 course	 of	 invasion	 and	 infection	 and	
repress	others	before	it	is	killed	by	the	host?		
28	
Until	 fifteen	 years	 ago,	 it	 was	 believed	 that	 bacterial	 gene	 expression	 was	 exclusively	 or	 mainly	
regulated	at	 the	 transcriptional	 level.	 In	 a	 simplified	 scheme	 this	means	 special	 proteins	 (so-called	











Figure	 4:	 Simplified	 illustration	 of	 transcriptional	 regulation	 in	 prokaryotes	 in	 accordance	 with	
“Lehninger	Principles	of	Biochemistry”	(Nelson	and	Cox,	2008).		
	
In	 the	past	decade,	 the	discovery	of	 small	non-coding	RNAs	 in	bacteria	has	 led	 to	a	paradigm	shift	
similar	 to	 the	 shift	 that	 took	 place	 with	 the	 discovery	 that	 RNA	 molecules	 can	 possess	 catalytic	
qualities,	subsequently	named	“ribozymes”	(ribonucleic	acid	enzymes)	(Cech	and	Steitz,	2014).	Post-
transcriptional	 regulation	 is	 now	 assumed	 to	 contribute	 significantly	 to	 the	 rapid	 adaptation	 of	
bacteria	to	changes	in	the	environment.		
As	 the	 name	 already	 indicates	 “post-transcriptional	 regulation”	 is	 the	 collective	 term	 for	 all	
regulatory	processes	after	DNA	has	been	transcribed	into	mRNA,	but	before	the	mRNA	is	translated	


























Salmonella	 enterica	 (Wassarman	 et	 al.,	 1999,	 Papenfort	 et	 al.,	 2006,	 Padalon-Brauch	 et	 al.,	 2008,	
Sittka	et	al.,	2008,	Vogel,	2009,	Waters	and	Storz,	2009,	Papenfort	and	Vogel,	2010,	Storz	et	al.,	2011,	
Erhardt	and	Dersch,	2015)	




is	 concealed	 or	 revealed	 by	 this	 structural	 rearrangements,	 translation	 can	 be	 prevented	 or	
supported	 (Mandal	 and	 Breaker,	 2004,	 Waters	 and	 Storz,	 2009,	 Schiano	 and	 Lathem,	 2012).	
Thermosensors,	sometimes	called	thermoswitches,	are	important	for	the	bacteria	to	respond	quickly	
to	 shifts	 in	 temperature.	 In	 Yersinia,	 production	 of	 the	 transcriptional	 activator	 VirF	 is	 post-
transcriptionally	thermoregulated	(see	paragraph	1.5.1.)	by	a	stem-loop	motif	 in	the	mRNA	formed	
immediately	upstream	of	the	virF	coding	sequence	at	25°C.	This	thermosensor	RNA	region	hides	the	
sequence	of	 the	ribosome	binding	site	and	thus	prevents	 the	ribosome	from	binding.	An	upshift	 in	
temperatures	 leads	 to	 a	 conformational	 change	 and	 a	 disappearance	 of	 the	 stem-loop,	 thereby	
enabling	the	ribosome	to	dock	and	start	translation	(Bohme	et	al.,	2012,	Schiano	and	Lathem,	2012).		
The	most	rapidly	growing	class	of	post-transcriptional	regulators	is	the	heterogeneous	group	of	small	
regulatory	RNAs	 (sRNAs).	With	exceptions	 (Friedman	et	 al.,	 2017)	 sRNAs	are	non-coding	RNAs,	 i.e.	
they	are	not	translated	into	proteins.	Most	sRNAs	modify	gene	expression	and	protein	production	by	
modulating	mRNA	stability	and	translation	(Waters	and	Storz,	2009)	(see	Figure	5).			
There	are	 sRNAs	 that	directly	bind	 to	proteins	 and	 influence	 their	 activity.	 For	example	 the	 sRNAs	
CsrB	and	CsrC	bind	the	carbon	storage	regulator	A	 (CsrA),	an	mRNA-binding	protein	that	 facilitates	
carbon	 usage,	 motility	 and	 sensitivity	 to	 antibiotics.	 CsrA	 allow	 the	 cell	 to	 perform	 a	 series	 of	
metabolic	adjustments	in	order	to	account	for	environmental	challenges	(Babitzke	and	Romeo,	2007,	
Romeo	et	al.,	2013,	LeGrand	et	al.,	2015).	
The	major	 known	 group	 of	 sRNAs,	 however,	 act	 by	 base-pairing	 to	 their	 target	mRNAs.	 They	 are	
typically	between	50-250	nt	long	(Michaux	et	al.,	2014)	and	generally	divided	into	two	subgroups:		
(1)	 The	 cis-acting	 antisense	 sRNAs	 are	 encoded	directly	 on	 the	 opposite	DNA	 strand	 of	 the	mRNA	
they	 influence.	 Therefore	 their	 defining	 feature	 is	 precise	 base-pairing	 because	 of	 their	 complete	
complementary	to	parts	of	the	mRNA	(Brantl,	2007).		
























































































for	 the	 replication	of	 the	RNA	bacteriophage	Qβ	 (Franze	de	Fernandez	et	al.,	1968),	Hfq	became	a	
focus	of	interest	with	the	onset	of	discoveries	of	new	sRNAs	and	the	awareness	of	its	crucial	role	in	
the	mediation	 of	 post-transcriptional	 regulation	 (Vogel	 and	 Luisi,	 2011).	 Hfq	 is	 a	 highly	 conserved	
protein	within	a	great	number	of	bacterial	species	and	has	orthologues	in	eukaryotes	and	archaea,	i.e.	
the	so-called	Sm	proteins	or	Sm-like	(LSm)	proteins	(Wilusz	and	Wilusz,	2005,	Rabhi	et	al.,	2011).	Hfq	




al.,	 2016,	 Holmqvist	 and	 Vogel,	 2018).	 According	 to	 the	 current	 state	 of	 research	 the	 Hfq-RNA-
interaction	 can	 be	 described	 in	 a	 simplified	 scheme	 as	 followed:	 the	 proximal	 face	 of	 Hfq-protein	
binds	 sRNA	at	U-rich	 sequences	 (Otaka	et	 al.,	 2011,	 Sauer	and	Weichenrieder,	 2011),	whereas	 the	
distal	 face	binds	mRNA	at	A-rich	regions	 (Link	et	al.,	2009,	Robinson	et	al.,	2014,	Updegrove	et	al.,	





Hfq-binding	 sRNAs,	 are	 composed	 of	 three	 components:	 an	 mRNA	 base-pairing	 region,	 a	 rho-
independent	transcription	terminator	and	an	Hfq-binding	site	(Otaka	et	al.,	2011).			
A	great	variety	of	 sRNAs	excists	differing	 in	 size,	 shape	and	sequence	and	 in	 the	way	 they	 interact	
with	Hfq,	not	always	strictly	following	the	general	model	of	Hfq-RNA-interaction	just	described	above	
(Zhang	et	al.,	2013,	Schu	et	al.,	2015,	Holmqvist	and	Vogel,	2018).		
In	Gram-negative	bacteria,	 the	RNA-chaperone	Hfq	 is	 involved	 in	different	 regulatory	mechanisms.	
By	interacting	with	sRNA	and/or	mRNA	it	can	stabilise	sRNA,	but	can	also	lead	in	other	cases	to	RNA	
degradation.	It	can	also	modulate	translation	by	facilitating	sRNA-mRNA-interaction	(Vogel	and	Luisi,	
2011,	 Kavita	 et	 al.,	 2018).	 In	 some	 cases	 Hfq	 can	 modulate	 post-transcriptional	 regulation	
independently	of	sRNA	binding	(Kavita	et	al.,	2018)	or	by	direct	protein-protein	interactions	(Sobrero	
and	Valverde,	2012).		
Hfq	 is	 considered	 an	 important	 and	 global	 player	 in	 post-transcriptional	 regulation.	 A	 summary	 of	




Figure	 6:	 	 Depending	 on	 the	 mode	 Hfq	 interacts	 with	 sRNAs,	 mRNAs	 or	 proteins,	 it	 can	 lead	 to	
different	effects:	By	binding	sRNAs	and/or	mRNAs	it	can	stabilze	them	and	their	interaction	with	each	
other.	But	it	can	also	ease	their	degradation.	By	interacting	directly	with	mRNAs	it	can	also	regulate	






























including	 pathogenicity	 and	 fitness	 in	 several	 Gram-negative	 bacteria.	 However,	 there	 are	 many	
differences	between	bacterial	 species	 in	what	Hfq	 influences	and	 to	what	extent	 (Chao	and	Vogel,	
2010).		
In	Y.	pestis	and	Y.	pseudotuberculosis	Hfq	is	essential	for	virulence	(Geng	et	al.,	2009,	Schiano	et	al.,	
2010).	However	Hfq	does	not	always	have	 identical	effects	 in	 these	 two	closely	 related	organisms.	
For	example	Hfq	promotes	growth	in	Y.	pestis,	but	no	growth	defect	can	be	seen	in	Δhfq	mutants	of	
Y.	 pseudotuberculosis	 (Bai	 et	 al.,	 2010).	 Further	 the	 T3SS	 seems	 differently	 affected	 in	 these	 two	
Yersinia	species	(Schiano	and	Lathem,	2012).		
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Hfq	 has	 an	 influence	 on	 the	 stress	 regulation	 and	 virulence	 of	 Y.	 pestis	 (Geng	 et	 al.,	 2009).	 For													
Y.	enterocolitica	only	an	impact	of	Hfq	on	the	expression	of	a	single	virulence	factor,	the	enterotoxin	
Yst,	 was	 reported	 in	 1995	 by	 Nakao	 et	 al	 (Nakao	 et	 al.,	 1995).	 No	 information	 about	 other	




O:8.	 By	 comparing	hfq-negative	mutants	with	 their	 parental	 strains	 it	 should	be	 assessed	whether	
Hfq	affects	the	bacterial	growth,	metabolism	and	resistance	to	stress.		
Moreover	 the	 impact	 of	 Hfq	 on	 production	 of	 important	 virulence	 factors	 (T3SS/Yop,	 adhesins,	
siderophores,	mouse	virulence)	should	be	examined.		
Special	emphasis	should	be	put	on	the	role	of	Hfq	in	post-transcriptional	regulation.		




































in	 place	 of	 the	 hfq	 gene.	 The	 third	 mutant	 strain	 SOR4	 was	 derived	 from	 WA314	 by	 unmarked	
deletion	of	hfq	(deletion	of	kanamycin	cassette).		
Macroscopically	on	most	agar	plates	bacterial	colonies	of	wildtype	and	mutant	strains	appeared	very	
similar.	 However	 light	 microscopy	 revealed	 that	 hfq	 mutants	 are	 enlarged	 in	 length	 and	 width	
compared	to	their	wildtype.		
Growth	of	hfq	mutants	 in	exponential	phase	was	 reduced	 in	 rich	and	minimal	media.	 In	 stationary	
phase	the	number	of	bacteria	was	significantly	reduced	compared	with	that	of	their	parental	strains,	





of	 JB580v	 and	 its	 mutant	 strain	 showed	 differences	 in	 the	 abundance	 of	 various	 proteins.	 Mass	
spectrometry	 allowed	 the	 identification	 of	 several	 proteins	 (listed	 in	 Table	 3	 and	 Table	 4	 in	
Kakoschke	et	al.	2014).	Deletion	of	hfq	resulted	in	a	decreased	production	of	proteins	playing	a	role	
in	 the	 lipid	 metabolism	 and	 transport,	 cell	 homeostasis,	 chaperone	 modulation,	 anaerobic	
respiration,	 translation	 or	 ATP-synthesis.	 Increase	 of	 protein	 production	 could	 be	 assigned	 to	
different	classes	comprising	chaperones	and	proteins	involved	in	stress	response,	carbon	and	amino	






defined	 minimal	 media	 suggested	 that	 Hfq	 affects	 the	 catabolism	 of	 mannitol,	 inositol	 and	 1,2-
propanediol.	Moreover	 further	 results	 showed	 that	 Hfq	 inhibits	 tryptophanase,	 indole	 production	
and	ornithine	decarboxylase	activity	and	therefore	also	impacts	nitrogen	metabolism.		
The	hfq	mutant	strains	showed	less	survival	to	acidic	stress.	Western	blot	analysis	revealed	a	lower	
presence	of	 the	enzyme	urease	 in	 the	strains	 that	 lack	hfq.	Hence	Hfq	promotes	the	production	of	
urease	 and	 subsequently	 enhances	 the	 resistance	 of	 Y.	 enterocolitica	 to	 low	 pH-environment.	
Whereas	 Hfq	 is	 also	 necessary	 for	 the	 bacteria’s	 ability	 of	 Y.	 enterocolitica	 to	withstand	 oxidative	
stress	(shown	by	higher	survival	of	the	parental	strains	in	the	presence	of	hydrogen	peroxide)	it	has	
no	 influence	on	antibiotic	 resistance	(no	difference	 in	minimal	 inhibitory	concentration	of	different	
antibiotics	tested).		
Using	 a	 pesticin	 sensitivity	 assay,	 immoblotting	 and	 a	 luciferase-based	 reporter	 assay,	 it	 could	 be	
shown	that	the	presence	of	Hfq	attenuates	the	production	of	the	siderophore	yersiniabactin	and	its	
receptor	 FyuA,	 which	 are	major	 virulence	 factors	 of	 Y.	 enterocolitica	 serotype	 O:8.	 In	 contrast	 to								
Y.	pseudotuberculosis	(Schiano	et	al.,	2010)	Hfq	had	no	impact	on	the	production	or	secretion	of	Yops	
in	vitro	in	Y.	enterocolitica.			
To	 monitor	 the	 growth	 state	 dependence	 of	 Hfq	 production	 in	 Y.	 enterocolitica,	 the	 protein	 was	
tagged	 with	 a	 FLAG	 epitope	 for	 immunodetection	 of	 whole	 cell	 lysates.	 Late	 exponential	 and	
stationary	growth	phase	favoured	production	of	Hfq.		




Ombeline	 Rossier	 and	Tamara	 Kakoschke	 planned	 and	 designed	 the	 experiments.	 Sara	 Kakoschke	
performed	stress	tests	and	the	experiments	on	 indole	production.	Giuseppe	Magistro	did	the	FyuA	
immunodetection	experiment	and	the	luciferase	reporter	assay	measuring	yersiniabactin	production.	
Marc	 Wirth	 (née	 Borath)	 performed	 mass	 spectrometry.	 Marc	 Wirth	 (née	 Borath)	 and	 Sören	
Schubert	 analysed	 mass	 spectrometry	 data.	 The	 deletion	 mutants	 were	 generated	 by	 Ombeline	
Rossier.	 Transformation	 and	 complementation	 experiments	 as	well	 as	 overexpression	 experiments	








Table	 1/Table	 2/Table	 3/Table	 4	 (Ombeline	 Rossier),	 Figure	 1	 (Tamara	 Kakoschke),	 Figure	 2	
(Ombeline	 Rossier),	 Figure	 3	 a,	 b	 (Ombeline	 Rossier,	 Tamara	 Kakoschke),	 Figure	 4	 a,	 b	 (Sara	









































inserted	 in	 the	 outer	 membrane	 that	 promote	 adherence	 of	 Y.	 enterocolitica	 to	 host	 cells.	 Using	
Northern	 blotting,	 translational	 fusions	 of	 the	 gene	 encoding	 green	 fluorescent	 protein	 with	
virulence-associated	 outer	membrane	 proteins	 and	 immunoblotting,	 the	 expression	 of	 a	 subset	 of	
adhesin	genes	and	production	of	the	proteins	in	the	wild-type	and	isogenic	hfq-negative	strain	were	
compared.	 To	 get	 evidences	 whether	 Hfq	 has	 a	 transcriptional	 or	 post-transcriptional	 effect,	 the	




Ail	 and	OmpX	production	are	decreased	by	Hfq	post-transcriptionally	 likely	by	destabilizing	ail	 and	
ompX	 transcripts	 in	 stationary	 phase.	 Production	 of	 invasin	 is	 rather	 increased	 by	 Hfq	 on	 the	
transcriptional	level.		A	closer	examination	revealed	that	Hfq	has	a	slight	influence	on	expression	of	
rovA	 and	 ompR	 (translational	 gfp-reporter	 fusions),	 encoding	 a	 transcriptional	 activator	 and	 a	
transcriptional	repressor	of	inv,	respectively.	
A	 more	 complex	 role	 of	 Hfq	 in	 regulating	 the	 expression	 of	 yadA	 was	 uncovered	 thanks	 to	
complementation	 experiments	 and	morphological	 analysis	 of	microcolonies	 (grown	 in	 3D-collagen	
gels	imitating	a	physiological	environment	for	forming	microabscesses)	and	the	production	of	YadA-
dependent	collagen	binding.	A	fine-tuned	amount	of	Hfq	seems	to	be	important	in	the	regulation	of	
YadA	 production:	 the	 lack	 of	 Hfq	 lead	 to	 a	 reduction	 of	 YadA	 production,	 but	 on	 the	 other	 hand	
additional	 copies	 of	 hfq	 expressed	 from	 plasmid	 pACYC184	 resulted	 in	 reduced	 amounts	 of	 YadA	
within	 the	OM.	Moreover	depending	upon	growth	conditions	and	bacterial	growth	phases	Hfq	can	
on	 the	one	hand	promote	YadA	production	 independently	of	 the	 transcriptional	 activator	VirF	but	
can	 also	 lead	 to	 a	 reduction	 of	 yadA	 transcripts.	 The	 discrepancy	 in	 yadA	 expression	 (reporter	
fusions)	 and	 the	 amount	 of	 surface-exposed	 YadA	 protein	 might	 result	 from	 post-translational	
mechanisms,	such	as	hfq-dependent	secretion	and/or	degradation	of	YadA	protein	in	the	periplasmic	
space.	 This	 hypothesis	 is	 supported	 by	 the	 increase	 of	 the	 YadA-cleaving	 protease	 DegP	 in	 the	
periplasmic	 space	 in	 the	hfq	mutant	 (observed	 in	 the	 proteomic	 analysis	 in	 Kakoschke	 et	 al.	 2014	
(Kakoschke	 et	 al.,	 2014).	 Future	work	 has	 to	 show	whether	 Hfq	 indirectly	 affects	 the	 transport	 of	
52	




By	analysing	 supernatant	and	 total	 cell	 protein	 compositions	 it	 could	be	 shown	 that	Hfq	 represses	
the	production	of	the	fimbriae-like	adhesin	MyfA	and	gfp-reporter	gene	fusion	experiments	revealed	
that	Hfq	inhibits	myfA	expression.	Both	down-regulations	happen	in	acidic	media,	but	not	at	neutral	
pH,	 indicating	 that	 the	 environmental	 pH	 can	 also	 play	 a	 role	 in	 Hfq-dependent	 regulation.	
Expression	 of	 myfA	 seems	 to	 be	 regulated	 transcriptionally	 in	 stationary	 phase	 at	 27°C	
(transcriptional	regulators:	MyfE/MyfF	(Iriarte	and	Cornelis,	1995,	Yang	and	Isberg,	1997))	and	post-
transcriptionally	in	exponential	phase	at	27°C	and	37°C.		




well	 as	 remodelling	 processes	 of	 LPS	 are	 known	 to	 be	 influenced	 by	 RovA	 and	 PhoP.	 As	 already	
shown	 for	 rovA	 transcriptional	 reporter	 fusion,	 the	 values	 for	 the	 phoP	 reporter	 fusion	were	 also	
slightly	 decreased	 in	 the	 hfq-negative	 strain.	 	 Consequently	 Hfq	 favours	 the	 production	 of	 LPS	
molecules	with	truncated	O-antigen	and	hexa-acylated	LPS	(LpxR↓).	Whether	such	structural	changes	
of	 LPS	 results	 in	 changes	 towards	 the	 O-antigen	 specific	 immune	 response	 remains	 worth	 to	 be	
studied.		
To	 clarify	 if	 Hfq	 not	 only	 influences	 the	 composition	 of	 the	 bacterial	 envelope	 and	 intracellular	
processes,	 but	 also	 plays	 a	 role	 in	 “injecting”	 virulence	 factors	 into	 host	 cells,	 a	 Yop-translocation	
assay	was	performed.	Therefore	 isolated	mice	 splenocytes	were	 infected	with	yersiniae	by	using	a	
YopH-β-lactamase	 reporter	 fusion	 (YopH-Bla-fusion).	 It	 could	be	shown	that	 translocation	of	YopH-
Bla	is	reduced	in	the	absence	of	hfq,	which	is	in	line	with	the	observed	decrease	of	adhesins	like	YadA	
and	InvA.			
Finally	 the	mouse	virulence	of	 isogenic	pairs	of	 yersiniae	 (wt	 versus	hfq	mutant)	was	 tested.	 In	an	
intraperitoneal	 mouse	 infection	 model	 Balb/c	 mice	 significantly	 showed	 fewer	 symptoms	 when	
inoculated	with	the	same	amount	of	mutants	lacking	hfq	in	comparison	to	the	isogenic	parent	strains.	
The	bacterial	loads	of	hfq	mutants	in	spleens	and	livers	were	clearly	reduced	in	comparison	to	those	
of	parent-strain	mice.	The	 impact	of	Hfq	on	virulence	 is	 likely	 to	stem	from	a	complex	 interplay	of	






Ombeline	 Rossier	 and	 Tamara	 Kakoschke	 designed	 the	 study.	 Clonings	 were	 done	 by	 Tamara		
Kakoschke	 and	 Kristin	 Adler.	 Tamara	 Kakoschke	 and	 Sara	 Kakoschke	 performed	 immunoblottings	
and	flow	cytometry	of	gfp-reporter	constructs.	LPS	staining	experiments	were	done	and	analysed	by	
Tamara	 Kakoschke.	 Sara	 Kakoschke	 performed	 the	 experiments	 with	 the	 3D-collagen	 gels.	 Kristin	
Adler	performed	the	Northern	Blottings	and	prepared	the	RNA	for	 the	RT-qPCR.	Catharina	Zeuzem	
performed	 the	 RT-qPCR.	 Hicham	 Bouabe	 generated	 the	 YopH-Bla	 reporter	 and	 executed	 the	
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S1	 a,	 b	 (Kristin	 Adler),	 Figure	 S1	 d,	 e	 (Catharina	 Zeuzem),	 Figure	 S2	 a,	 b	 (Sara	 Kakoschke,	Tamara	



























eine	 Gensequenz	 identifiziert	 werden,	 die	 eine	 über	 80-prozentige	 Sequenzähnlichkeit	 und	
Sequenzübereinstimmung	mit	dem	bekannten	hfq	Gen	von	E.	coli	Bakterien	aufwies.	Um	Kenntnisse	
über	die	Rolle	des	Proteins	Hfq	bei	Y.	enterocolitica	Bakterien	zu	erhalten,	wurden	drei	voneinander	
unabhängige	 Mutanten	 generiert.	 Dazu	 wurde	 bei	 zwei	 genotypisch	 unterschiedlichen																										
Y.	enterocolitica	Stämmen	des	Serotyps	O:8,	WA-314	und	JB580v	(letzterer	ein	Derivat	des	Stammes	
8081),	 die	 hfq	 Gensequenz	 deletiert.	 Dadurch	 erhielt	 man	 vom	 WA314	 abstammend	 die	 hfq-
negativen	 Stämme	 SOR3	 (hfq::KanR)	 und	 SOR4	 (Δhfq)	 und	 von	 JB580v	 abstammend	 SOR17	
(hfq::KanR).	
Auf	 Agarplatten	 unterschieden	 sich	 die	 Kolonien	 dieser	 Stämme,	 makroskopisch	 betrachtet,	 nicht	
wesentlich	 von	 denen	 ihrer	 Ausgangsstämme.	Mikroskopisch	 stellten	 sich	 allerdings	 die	 einzelnen	
Bakterienzellen	der	Mutanten	gegenüber	ihren	Ausgangsstämmen	vergrößert	und	elongiert	dar.		
Ihr	 Wachstumsverhalten	 (getestet	 in	 reichhaltigen	 sowie	 in	 Minimalmedien)	 zeigte	 sich	 in	 der	
exponentiellen	Phase	verzögert.	In	der	stationären	Phase	von	Flüssigkulturen	wurde	letztendlich	eine	
geringere	 optische	 Dichte	 (OD600)	 erreicht	 und	 auf	 Agarplatten	 wurden	 weniger	 koloniebildende	
Einheiten	 gezählt.	 Komplementationsversuche	 zeigten,	 dass	 über	 ein	 Plasmid	 zusätzlich	 in	 die	
Ausgangsstämme	 eingeführte	hfq-Genkopien	 zu	 einem	Wachstumsanstieg	 über	 das	 physiologische	
Maß	hinaus	führten.	Insgesamt	lässt	sich	schlussfolgern,	dass	Hfq	das	Wachstum	von	Y.	enterocolitica	
fördert.		
Eine	 zweidimensionale	 Gelelektrophorese	 zeigte	 Unterschiede	 zwischen	 JB580v	 und	 SOR17	 im	
Vorkommen	 von	 Membranproteinen.	 Massenspektrometrische	 Analysen	 konnten	 einige	 dieser	
Proteine	 identifizieren,	 von	 denen	 bekannt	 war,	 dass	 sie	 entweder	 eine	 Rolle	 im	 bakteriellen	
Stoffwechsel	 oder	 der	 Stressresistenz	 von	 Y.	 enterocolitica	 spielten	 oder	 Bestandteile	 der	
Bakterienwand	waren.	 	 Insgesamt	wies	dieses	 Ergebnis	 auf	 einen	breiten	Einfluss	 von	Hfq	 auf	den	
Metabolismus	und	die	Produktion	von	Virulenzfaktoren	hin.	So	waren	in	der		Δhfq-Mutante	Proteine	
herunterreguliert,	die	beispielsweise	eine	Rolle	im	Lipidstoffwechsel	und	–transport	spielen	bzw.	an	
der	 Zellhomöostase,	 der	 Modulation	 von	 Chaperonen,	 der	 anaeroben	 Atmung	 	 oder	 der	 ATP-
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Synthese	beteiligt	sind.	 In	größeren	Mengen	vertreten	waren	hingegen	bestimmte	Chaperone	bzw.	
Proteasen,	 die	 im	 Rahmen	 der	 bakteriellen	 Stressantwort	 von	 Bedeutung	 sind	 oder	 wichtige	
Funktionen	 im	 Stoffwechsel,	 Peptidtransport	 oder	 tRNA-Synthese	 einnehmen.	 Andere	 wiederum	
sind	 Virulenzproteine	 der	 äußeren	 Bakterienmembran,	 wie	 beispielsweise	 der	 Siderophorrezeptor	
FyuA.	 Die	 einzelnen	 Proteine	 und	 ihre	 jeweilige	 Beschreibung	 sind	 in	 Tabelle	 3	 und	 Tabelle	 4	 in	
Kakoschke	et	al.	2014	aufgeführt.		
Weitere	 molekularbiologische	 Untersuchungen	 und	 Wachstumsversuche	 auf	 definierten	
Minimalmedien	 zeigten	 einen	 Einfluss	 von	 Hfq	 auf	 den	 Abbau	 von	 Kohlehydraten	 und	
Zuckeralkoholen,	insbesondere	Mannitol,	Sorbitol	und	1,2-Propandiol.	Zudem	konnte	gezeigt	werden,	
dass	 Hfq	 die	 Tryptophanase,	 Indolproduktion	 und	 die	 Ornithin-Dekarboxylase	 Aktivität	 hemmt.	
Folglich	 hat	 dieses	 regulatorische	 Protein	 sowohl	 auf	 den	 Kohlehydrat-	 als	 auch	 den	
Stickstoffhaushalt	von	Y.	enterocolitica	Einfluss.		
Die	Säureresistenz	war	in	den	hfq-negativen	Stämmen	geringer.	Ebenso	konnten	in	diesen	Mutanten	
deutlich	 kleinere	Mengen	 an	 Urease	 nachgewiesen	 werden.	 Somit	 befähigt	 Hfq	 die	 Bakterien	mit	
einem	besseren	Überleben	 in	einer	Umgebung	mit	niedrigem	pH-Wert.	Zudem	konnte	eine	höhere	
Überlebensrate	 auch	 gegenüber	 oxidativem	 Stress	 nachgewiesen	 werden.	 In	 Bezug	 auf	
Antibiotikaresistenzen	ergaben	sich	keine	signifikanten	Unterschiede.		
Durch	Messung	der	 Pesticin-Sensitivität,	Western-Blot-Analysen	und	Verwendung	 eines	 Luciferase-
Tests	 konnte	 gezeigt	 werden,	 dass	 Hfq	 die	 Produktion	 des	 Siderophors	 Yersiniabactin	 und	 dessen	
Rezeptor	 FyuA	 inhibiert.	 Allerdings	 konnte,	 im	 Gegensatz	 zu	 Y.	 pseudotuberculosis	 (Schiano	 et	 al.,	
2010),	bei	Y.	enterocolitica	kein	Einfluss	auf	die	Menge	und	Sekretion	der	Yop-Proteine	nachgewiesen	
werden.		
Um	 herauszufinden	 in	 welcher	 bakteriellen	Wachstumsphase	 die	 Produktion	 des	 Hfq-Proteins	 am	
größten	ist,	wurde	es	mit	einem	FLAG-Epitop	markiert.	Immunoblots	von	Ganzzelllysaten	wiesen	die	
größte	Menge	an	Hfq	in	der	exponentiellen	und	stationären	Phase	auf.		






Ombeline	 Rossier	 und	 Tamara	 Kakoschke	 konzipierten	 und	 planten	 die	 Versuche.	 Sara	 Kakoschke	
führte	 Stressresistenztests	 und	 die	 Experimente	 zur	 Indolproduktion	 durch.	 Giuseppe	 Magistro	
führte	 den	 FyuA-Immunodetektionsversuch	 und	 den	 Luziferase-Reporter-Assay	 durch.	Marc	Wirth	
(geb.	 Borath)	 führte	 die	Massenspektrometrie	 aus.	Marc	Wirth	 (geb.	 Borath)	 und	 Sören	 Schubert	
werteten	 die	 Daten	 der	 Massenspektrometrieanalyse	 aus.	 Ombeline	 Rossier	 generierte	 die	
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Deletionsmutanten.	Tamara	 Kakoschke	 führte	die	 Transformationen	 sowie	die	Komplementations-	
und	 Überexpressionsversuche	 durch.	 Die	 Wachstumsversuche	 wurden	 von	 Tamara	 Kakoschke	
durchgeführt.	Die	Analysen	zur	Bakterienmorphologie	inklusive	Lichtmikroskopie	übernahm	Tamara	
Kakoschke.	 Ombeline	 Rossier	 wertete	 die	 2-DE	 Gele,	 die	 Yop-Sekretion	 sowie	 die	 Produktion	 des	
Hfq-Proteins	 aus.	 	 Tamara	 Kakoschke	 führte	 die	 Westernblots	 und	 Experimente	 zur	
Ureaseproduktion	 durch.	 Sören	 Schubert	 und	 Jürgen	 Heesemann	 stellten	 Reagenzien,	Materialien	
und	 Analyseinstrumente	 und	 –geräte	 zur	 Verfügung.	 Jürgen	 Heesemann	 unterstützte	 durch	




Tabelle	 1/Tabelle	 2/Tabelle	 3/Tabelle	 4	 (Ombeline	 Rossier),	 Bild	 1	 (Tamara	 Kakoschke),	 Bild	 2	
(Ombeline	Rossier),	Bild	3	a,	b	(Tamara	Kakoschke,	Ombeline	Rossier),	Bild	4	a,	b	(Sara	Kakoschke),	































Der	 Einfluss	 von	 Hfq	 auf	 die	 Produktion	 von	 Adhäsinen	 und	 auf	 das	 Virulenzverhalten	 von																				
Y.	 enterocolitica	 ist	 wesentlicher	 Gegenstand	 dieser	 Publikation.	 Adhäsine	 sind	
Pathogenitätsfaktoren,	die	ein	Anhaften	der	Bakterien	an	Wirtszellen	ermöglichen.	Mittels	Northern	
Blots,	translationalen	Fusionen	mit	dem	gfp-Gen	und	Immunoblots	wurde	die	Produktion	einer	Reihe	
von	 Adhäsinen	 und	 die	 Expression	 ihrer	 Gene	 in	 den	 Wildtypstämmen	 und	 in	 den	 hfq-negativen	
Stämmen	 untersucht	 und	 verglichen.	 Um	 zu	 untersuchen,	 ob	 Hfq	 auf	 transkriptioneller	 oder	
posttranskriptioneller	 Ebene	 agiert	 wurde	 der	 jeweilige	 Promotor	 einer	 translationalen	 Genfusion		
durch	einen	Plac	Promotor	ersetzt.		
Es	konnte	gezeigt	werden,	dass	Hfq	die	wichtigen	Adhäsine	Ail,	OmpX,	InvA,	YadA	und	MyfA	reguliert.		
Ail	 und	 OmpX	 werden	 posttranskriptional	 (wahrscheinlich	 durch	 eine	 Destabilisierung	 ihrer	
Transkripte	 in	der	stationären	Phase)	durch	Hfq	gehemmt.	 Invasin	wird	durch	Hfq	eher	positiv	und	
auf	Ebene	der	Transkription	beeinflusst.	Nähere	Untersuchungen	zeigten	eine	Wirkung	von	Hfq	auf	
die	 Expression	 des	 Gens	 rovA,	 welches	 einen	 aktivierenden	 Transkriptionsfaktor	 von	 InvA	 kodiert,	
und	auf	die	Expression	des	Gens	ompR,	welches	den	transkriptionellen	Repressor	kodiert.		
Mithilfe	 von	 Komplementationsversuchen	 und	 Experimenten	 mit	 3D-Kollagen-Gelen	 zur	
morphologischen	 Beschreibung	 von	 Mikrokolonien	 und	 ihrer	 Interaktion	 mit	 dem	 umliegenden	
Kollagen	konnte	eine	komplexere	Funktion	von	Hfq	bei	der	Regulation	von	YadA	erschlossen	werden.	
Hierbei	scheint	zunächst,	die	vorhandene	Menge	an	Hfq	Protein	ausschlaggebend	zu	sein:	Wenn	Hfq	
in	Y.	enterocolitica	 fehlt	 resultiert	dies	 in	einer	geringeren	Menge	an	YadA-Protein.	Allerdings	 führt	
auch	eine	Überexpression	von	hfq	(über	das	Plasmid	pACYC184)	zu	einer	reduzierten	Produktion	von	
YadA.	Es	konnte	zudem	gezeigt	werden,	dass	Hfq	 je	nach	Wachstumsbedingungen	und	-phasen	die	
YadA-Produktion	 unabhängig	 von	 dem	 Aktivator	 VirF	 fördern	 kann,	 aber	 unter	 bestimmten	
Bedingungen	auch	die	Menge	an	yadA-Transkripten	reduzieren	kann.	Diese	Diskrepanz	bezüglich	der	
yadA-Expression	 und	 der	 nachweisbaren	 Menge	 an	 YadA-Protein	 könnte	 ein	 Ergebnis	 post-
translationaler	 Modifikationen	 sein.	 Hierbei	 könnten	 eine	 hfq-abhängige	 Sekretion	 und/oder	 der	
Abbau	 von	 YadA-Protein	 im	 periplasmatischen	 Raum	 in	 Frage	 kommen.	 Diese	 Annahme	 wird	
dadurch	 unterstützt,	 dass	 die	 YadA-spaltende	 Protease	 DegP	 in	 der	 hfq-Mutante	 vermehrt	
nachgewiesen	 wurde	 (siehe	 Proteomanalyse	 in	 Kakoschke	 et	 al.	 2014).	 Letztendlich	 müssen	
zukünftige	 Arbeiten	 zeigen,	 ob	 Hfq	 indirekt	 den	 Transport	 von	 YadA	 über	 den	 periplasmatischen	
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Raum,	die	 Proteinfaltung	und	die	 korrekte	 Insertion	 von	YadA	 in	der	 äußeren	Membran	 sowie	die	
Stabilität	 der	 yadA	 mRNA	 beeinflusst.	 Was	 man	 aber	 bereits	 sagen	 kann:	 Hfq	 scheint	 mit	





und	nicht	 in	 neutralem	Medium.	Der	 pH-Wert	 der	Umgebung	 scheint	 also	 auch	 einen	 Einfluss	 auf	
Hfq-abhängige	Regulation	zu	haben.	Die	Regulation	der	myfA	Expression	zeigte	sich	am	ehesten	auf	
transkriptioneller	 Ebene	 während	 der	 stationären	 Phase	 bei	 27°C	 und	 auf	 posttranskriptioneller	
Ebene	während	der	exponentiellen	Phase,	hier	sowohl	bei	27°C	als	auch	37°C.		





von	 LPS).	 Es	 ist	 bereits	 bekannt,	 dass	 die	 Expression	des	Gens	 lpxR	 sowie	Umbauprozesse	des	 LPS	
durch	RovA	und	PhoP	beeinflusst	werden.	Wie	bereits	für	rovA	gezeigt,	 ist	auch	die	Expression	von	
phoP	 in	 Abwesenheit	 des	hfq-Gens	 in	Y.	 enterocolitica	 leicht	 reduziert.	 Folglich	 begünstigt	 Hfq	 die	
Produktion	 eines	 hexa-acetylierten	 LPS-Moleküls	 (LpxR↓)	 mit	 verkürztem	 O-Antigen.	 Ob	 die	
strukturellen	 Veränderungen	 des	 LPS-Moleküls	 die	 O-Antigen	 vermittelte	 Immunantwort	
beeinflussen	sollte	Gegenstand	weiterer	Untersuchungen	werden.		
Abgesehen	von	der	Bakterienwandzusammensetzung	und	intrazellulären	Prozessen	wurde	auch	die	
„Injektion“	 von	 Virulenzfaktoren	 in	 Wirtszellen	 in	 Abhängigkeit	 von	 Hfq	 untersucht.	 In	 einem	
Translokationsversuch	 unter	 Verwendung	 eines	 β-Laktamase	 Reportersystems	 (YopH-Bla-Fusion)	
wurden	 hierzu	 murine	 Splenozyten	 mit	 Yersinien	 infiziert.	 In	 der	 hfq-Mutante	 zeigte	 sich	 eine	
geringere	 Translokation	 von	 YopH-Bla	 in	 die	 Zielzellen,	 was	 auch	 vereinbar	mit	 der	 beobachteten	
Abnahme	der	Adhäsine	YadA	und	InvA	ist.		
Schließlich	 wurden	 Balb/c	 Mäuse	 intraperitoneal	 mit	 Yersinien	 (hfq-Mutante	 und	 jeweiliger	
Ausgangsstamm)	 infiziert,	 um	 den	 Einfluss	 von	 Hfq	 auf	 die	 Virulenz	 von	 Y.	 enterocolitica	 im	
Tiermodell	zu	untersuchen.	Die	mit	den	Ausgangsstämmen	infizierten	Mäuse	(bei	gleicher	Menge	an	
injizierten	Bakterien)	 zeigten	eine	 stärkere	Ausprägung	der	 Krankheitssymptome	und	eine	 erhöhte	
Bakterienbelastung	 der	 Organe	 Leber	 und	 Milz	 als	 die	 mit	 der	 hfq-Mutante	 infizierten	 Tiere.	 In	
Zusammenschau	 der	 bisherigen	 Ergebnisse	 scheint	 der	 Einfluss	 von	 Hfq	 auf	 die	 Virulenz	 von	 Y.	
enterocolitica	 in	 einem	 komplexen	 Zusammenspiel	 verschiedener	 Funktionen	 begründet.	 Darunter	
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Ombeline	 Rossier	 entwarf	 die	 Studie.	 Ombeline	 Rossier	 und	 Tamara	 Kakoschke	 planten	 die	
Experimente	 und	 ihr	 Design.	 Die	 Klonierungen	 wurden	 von	 Tamara	 Kakoschke	 und	 Kristin	 Adler	
durchgeführt.	 Tamara	 Kakoschke	 und	 Sara	 Kakoschke	 führten	 die	 Immunoblots	 und	 die	 FACS-
Analysen	der	hergestellten	gfq-Reporter-Stämme	durch.	Die	LPS-Färbeversuche	wurden	von	Tamara	
Kakoschke	 geplant,	 durchgeführt	 und	 analysiert.	 Sara	 Kakoschke	 führte	 die	 Experimente	 zur	
Kollagen-YadA-Interaktion	 in	 3D-Kollagen-Gel-Kammern	 durch.	 Kristin	 Adler	 machte	 die	 Northern	
Blots	und	bereitete	die	RNA	für	die	RT-qPCR	vor.	Catharina	Zeuzem	führte		die	RT-qPCR	aus.	Hicham	
Bouabe	 generierte	 den	 YopH-Bla-Reporter	 und	 führte	 die	 Translokationsversuche	 durch.	 Tamara	
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S1/S2	 (Ombeline	 Rossier),	 Tabelle	 S3	 (Catharina	 Zeuzem,	Ombeline	 Rossier),	 Tabelle	 S4	 (Ombeline	






Wachstum,	 die	 Zellmorphologie,	 den	 Metabolismus	 und	 die	 Widerstandsfähigkeit	 von																										
Y.	 enterocolitica	 wirkt,	 belegt	 die	 zweite	 Publikation	 den	 Einfluss	 auf	 weitere	 Virulenzfaktoren	
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